CLBPFCALIWAY BIOPHARMACEUTICALS CO.

About CALIWAY BIOPHARMACEUTICALS CO. (CLBPF)

CALIWAY BIOPHARMACEUTICALS CO. (CLBPF) is a company headquartered in Xizhi Dist., New Tai, Taiwan whose shares trade over-the-counter on the Pink tier.

Caliway Biopharmaceuticals Co., Ltd., together with its subsidiaries, engages in the development of drugs for aesthetic medicine and chronic inflammation. The company develops CBL-514, an investigational drug, which is in Phase 2 clinical trial for non-surgical fat reduction and Dercum's disease, as well as for cellulite treatment. It is also developing CBA-539, which is in preclinical stage for central obesity, hyperpigmentation, and skin aging, as well as offers dietary supplements.

CLBPF key facts

Ticker symbol

CLBPF

Market tier

Pink

Headquarters

Xizhi Dist., New Tai, Taiwan

Reporting standard

International Reporting: Taipei Exchange

Audit status

Not Available

Fiscal year end

12/31

Explore more: Pink stocks · OTC stocks starting with C